IP Library Patent Application 13088095
Patent Application
App. No. 13/088,095

METHODS AND DEVICES FOR INJECTION OF A SUBSTANCE INTO TISSUE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/088,095
Abstract

Substances are injected (e.g. laser injected) into skin tissue in order to change optical and/or mechanical properties of the tissue. Methods include ablating one or more micro-holes into tissue, pushing a substance into the one or more micro-holes with energy from the creation of the mirco-holes, with acoustic energy, and/or with laser energy. A container component is filled with the substance to be injected into the skin tissue.

Claims (36)

1 . A method of driving a substance into a subject's skin, comprising:

placing a substance in contact with or in proximity to a portion of the skin;

applying energy to said skin portion so as to generate a plurality of micro-holes therein; and

applying energy to at least a portion of said substance to generate pressure for forcing at least a portion of said substance into one or more of the plurality of micro-holes.

2 . The method of claim 1 , wherein at least a portion of said substance changes its phase into a gaseous phase.

3 . The method of claim 1 , wherein at least a portion of said substance changes its phase into a liquid phase.

4 . The method of claim 1 , wherein said substance is disposed in a container having a surface adapted for contact with the skin.

5 . The method of claim 4 , wherein said surface is frangible and perforates in response to applying energy.

6 . The method of claim 4 , wherein said container is maintained in contact with the skin through the application of the energy to the skin and the substance.

7 . The method of claim 1 , wherein said substance alters the optics of the skin.

8 . The method of claim 7 , wherein said substance optically clears at least a portion of the skin appearance.

9 . The method of claim 7 , wherein said substance lightens at least a portion of the skin appearance.

10 . The method of claim 7 , wherein said substance protects at least a portion of the skin from UV-light.

11 . The method of claim 7 wherein the substance within said micro-holes changes over time such that the optics of the skin returns to the unaltered optical appearance.

12 . The method of claim 1 , wherein the plurality of micro-holes have a depth at or above the dermal epidermal junction and the substance forced into the micro-holes are at a depth at or above the dermal epidermal junction.

13 . The method of claim 1 , wherein the plurality of micro-holes have a depth below the dermal epidermal junction and the substance forced into the micro-holes are at a depth below the dermal epidermal junction.

14 . The method of claim 1 , wherein the substance is disposed in a container, the container provides a seal with the skin when the container is in contact with the skin.

15 . A method of driving a substance into a subject's skin, comprising:

placing a container housing in contact with a portion of the skin, said container housing defining a compartment containing a substance therein, the container housing configured to seal the compartment between the skin and the container housing when the compartment is in contact with the skin; and

applying ablative energy through at least a portion of the container housing thereby ablating said skin portion and so as to generate a plurality of micro-holes and such that a pressure within the compartment increases and drives at least a portion of said substance into said micro-holes with said increased pressure.

16 . The method of claim 15 , wherein at least a portion of said substance driven into said micro-holes is in a gaseous phase.

17 . The method of claim 15 , wherein at least a portion of said substance driven into said micro-holes is in a liquid phase.

18 . The method of claim 15 , wherein the container housing has a frangible surface that perforates in response to ablation.

19 . The method of claim 15 , wherein said container housing is maintained in contact with the skin through the application of the ablative energy to the skin and the substance.

20 . The method of claim 15 , wherein said substance alters the optics of the skin.

21 . The method of claim 20 , wherein said substance optically clears at least a portion of the skin appearance.

22 . The method of claim 20 , wherein said substance lightens at least a portion of the skin appearance.

23 . The method of claim 20 , wherein said substance protects at least a portion of the skin from UV-light.

24 . The method of claim 1 , wherein the plurality of micro-holes have a depth at or above the dermal epidermal junction and the substance forced into the micro-holes are at a depth at or above the dermal epidermal junction.

25 . The method of claim 1 , wherein the plurality of micro-holes have a depth below the dermal epidermal junction and the substance forced into the micro-holes are at a depth below the dermal epidermal junction.

26 . A container component for driving a substance into tissue, the component comprising:

a compartment;

a window, at least a portion of the window is optically transparent to laser energy, the window reflects at least a portion of the sonic energy created when the laser energy is applied to tissue and the window prevents escape of the reflected acoustic sonic energy from the compartment; and

a wall, wherein at least a portion of the wall can form a seal with a tissue surface.

27 . The container of claim 26 further comprising an orifice through which a substance is inserted into the compartment.

28 . The container of claim 26 , wherein the window comprises sapphire.

Assignments (2)
MERGER Recorded Jan 8, 2014
From: PALOMAR MEDICAL TECHNOLOGIES, INC.
To: PALOMAR MEDICAL TECHNOLOGIES, LLC
Reel/Frame 031936/0704 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2011
From: ALTSHULER, GREGORY B.; YAROSLAVSKY, ILYA; TABATADZE, DAVID; TUCHIN, VALERY V.; BELIKOV, ANDREI; EROFEEV, ANDREI
To: PALOMAR MEDICAL TECHNOLOGIES, INC.
Reel/Frame 026514/0945 →